Literature DB >> 18852267

Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II.

Timothy M Ryan1, Geoffrey J Howlett, Michael F Bailey.   

Abstract

The misfolding and self-assembly of proteins into amyloid fibrils that occurs in several debilitating and age-related diseases is affected by common components of amyloid deposits, notably lipids and lipid complexes. We have examined the effect of the short-chain phospholipids, dihexanoylphosphatidylcholine (DHPC) and dihexanoylphosphatidylserine (DHPS), on amyloid fibril formation by human apolipoprotein C-II (apoC-II). Micellar DHPC and DHPS strongly inhibited apoC-II fibril formation, whereas submicellar levels of these lipids accelerated apoC-II fibril formation to a similar degree. These results indicate that the net negative charge on DHPS, compared with the neutrally charged DHPC, is not critical for either the inhibition or activation process. We also investigated the mechanism for the submicellar, lipid-induced activation of fibril formation. Emission data for fluorescently labeled apoC-II indicated that DHPC and DHPS stimulate the early formation and accumulation of oligomeric species. Sedimentation velocity and equilibrium experiments using a new fluorescence detection system identified a discrete lipid-induced tetramer formed at low apoC-II concentrations in the absence of significant fibril formation. Seeding experiments showed that this tetramer was on the fibril-forming pathway. Fluorescence resonance energy transfer experiments established that this tetramer forms rapidly and is stabilized by submicellar, but not micellar, concentrations of DHPC and DHPS. Several recent studies show that oligomeric intermediates in amyloid fibril formation are toxic. Our results indicate that lipids promote on-pathway intermediates of apoC-II fibril assembly and that the accumulation of a discrete tetrameric intermediate depends on the molecular state of the lipid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852267      PMCID: PMC3259869          DOI: 10.1074/jbc.M804004200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

Review 2.  The structural basis for amyloid formation by plasma apolipoproteins: a review.

Authors:  Danny M Hatters; Geoffrey J Howlett
Journal:  Eur Biophys J       Date:  2002-03       Impact factor: 1.733

3.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

4.  On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation.

Authors:  Peter Schuck
Journal:  Anal Biochem       Date:  2003-09-01       Impact factor: 3.365

5.  A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.

Authors:  Kathryn J Moore; Joseph El Khoury; Lea A Medeiros; Kinya Terada; Changiz Geula; Andrew D Luster; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-09-17       Impact factor: 5.157

6.  Fluorescence detection for the XLI analytical ultracentrifuge.

Authors:  Ian K MacGregor; Arthur L Anderson; Thomas M Laue
Journal:  Biophys Chem       Date:  2004-03-01       Impact factor: 2.352

7.  Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition.

Authors:  Jennifer Vistica; Julie Dam; Andrea Balbo; Emine Yikilmaz; Roy A Mariuzza; Tracey A Rouault; Peter Schuck
Journal:  Anal Biochem       Date:  2004-03-15       Impact factor: 3.365

8.  Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis.

Authors:  Anna Sanders; C Jeremy Craven; Lee D Higgins; Silva Giannini; Matthew J Conroy; Andrea M Hounslow; Jonathan P Waltho; Rosemary A Staniforth
Journal:  J Mol Biol       Date:  2004-02-06       Impact factor: 5.469

9.  Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.

Authors:  Marcus Bokvist; Fredrick Lindström; Anthony Watts; Gerhard Gröbner
Journal:  J Mol Biol       Date:  2004-01-23       Impact factor: 5.469

10.  Fibrillar amyloid protein present in atheroma activates CD36 signal transduction.

Authors:  Lea A Medeiros; Tayeba Khan; Joseph B El Khoury; Chi L L Pham; Danny M Hatters; Geoffrey J Howlett; Roland Lopez; Kevin D O'Brien; Kathryn J Moore
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  12 in total

1.  Use of fluorescence-detected sedimentation velocity to study high-affinity protein interactions.

Authors:  Sumit K Chaturvedi; Jia Ma; Huaying Zhao; Peter Schuck
Journal:  Nat Protoc       Date:  2017-08-03       Impact factor: 13.491

2.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

3.  Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.

Authors:  Timothy M Ryan; Chai L Teoh; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

4.  Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool.

Authors:  Maya A Olshina; Lauren M Angley; Yasmin M Ramdzan; Jinwei Tang; Michael F Bailey; Andrew F Hill; Danny M Hatters
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

5.  NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Authors:  Timothy M Ryan; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

6.  Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42).

Authors:  Timothy M Ryan; Anna Friedhuber; Monica Lind; Geoffrey J Howlett; Colin Masters; Blaine R Roberts
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

Review 7.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

8.  Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine.

Authors:  Timothy M Ryan; Michael D W Griffin; Duncan J McGillivray; Robert B Knott; Kathleen Wood; Colin L Masters; Nigel Kirby; Cyril C Curtain
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

9.  NUTS and BOLTS: applications of fluorescence-detected sedimentation.

Authors:  Rachel R Kroe; Thomas M Laue
Journal:  Anal Biochem       Date:  2008-12-06       Impact factor: 3.365

10.  N- and C-terminal regions of αB-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation.

Authors:  Emily E Selig; Courtney O Zlatic; Dezerae Cox; Yee-Foong Mok; Paul R Gooley; Heath Ecroyd; Michael D W Griffin
Journal:  J Biol Chem       Date:  2020-05-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.